3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
109
Leukemia, Myeloid, Acute
102
Leukemia
97
Myelodysplastic Syndromes
87
Precursor Cell Lymphoblastic Leukemia-Lymphoma
74
Lymphoma, Non-Hodgkin
71
Lymphoma
71
Multiple Myeloma
70
Hodgkin Disease
68
Lymphoma, Mantle-Cell
53
Lymphoma, Follicular
51
Lymphoma, Large B-Cell, Diffuse
50
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
45
Lymphoma, B-Cell, Marginal Zone
44
Myeloproliferative Disorders
43
Congenital Abnormalities
41
Burkitt Lymphoma
37
Leukemia, Myelomonocytic, Chronic
36
Waldenstrom Macroglobulinemia
32
Leukemia, Myeloid, Accelerated Phase
32
Primary Myelofibrosis
31
Melanoma
31
Lymphoma, Large-Cell, Immunoblastic
31
Leukemia, Myeloid, Chronic-Phase
31
Blast Crisis
28
Recurrence
27
Neoplasms, Plasma Cell
25
Hematologic Neoplasms
24
Lymphoma, T-Cell, Cutaneous
23
Dendritic Cell Sarcoma, Interdigitating
23
Interventions
tucatinib
1
sapanisertib
1
Trastuzumab
1
Rituximab
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Meningeal Neoplasms
×
fludarabine phosphate
×
Clear all
No trials found.